Showing 1371-1380 of 1491 results for "".
- Online Exclusive: New Practice-changing Research Links ARD to Bacteriahttps://practicaldermatology.com/news/online-exclusive-new-practice-changing-research-links-rad-to-bacteria/2461701/As many as 95% of people undergoing radiation treatment for cancer will develop acute radiation dermatitis (ARD). Little, however, has been known about why this condition occurs, and there are no widely adapted or standardized treatments for preventing severe ARD. New research may chang
- Study: UV Exposure Produces Epigenetic Changes in the Epidermis to Induce Skin Pigmentationhttps://practicaldermatology.com/news/study-uv-exposure-produces-epigenetic-changes-in-the-epidermis-to-induce-skin-pigmentation/2460905/Exposure to the sun's ultraviolet (UV) rays produces epigenetic changes in the epidermis to induce skin pigmentation, a new study shows. UV exposure causes DNA damage in epidermal cells and is a leading cause of skin cancers. To protect from the damaging effects of UV exposure, epid
- Skin Cancer Foundation Champions for Change Gala Goes Virtualhttps://practicaldermatology.com/news/skin-cancer-foundation-champions-for-change-gala-goes-virtual/2460783/The Champions for Change Gala, the Skin Cancer Foundation’s signature fundraising event, be held virtually, Tuesday, May 11. Proceeds from the annual event support the organization’s educational campaigns, community programs, and research initiatives. The event will be
- Visible Light from the Sun Causes Pigmentary Skin Changeshttps://practicaldermatology.com/news/visible-light-from-the-sun-causes-pigmentary-skin-changes/2460768/Visible light from the sun plays a significant role in causing pigmentary skin changes, particularly in people with skin of color, according to information presented at AAD VMX 2021. “We know from decades of research that unprotected exposure to ultraviolet light from the sun can
- Changes Afoot at Valeant Pharmaceuticalshttps://practicaldermatology.com/news/changes-afoot-at-valeant-pharmaceuticals/2458527/Amid reports that its Obagi Medical Products and Solta Medical units are on the block, Valeant Pharmaceuticals is assuring investors that the company is focused on the future and has plans to fix its dermatology unit. Valeant CEO Joseph Papa cite
- ArteFill Changes Name to Bellafillhttps://practicaldermatology.com/news/artefill-changes-name-to-bellafill/2459051/Suneva Medical, Inc.’s ArteFill dermal filler has been rebranded as Bellafill in the US. "We feel that the brand Bellafill better embodies the transformational outcomes this unique product can provide to our customers and th
- Call for Entries: Sanofi Genzyme and Regeneron Launches 2020 ‘Agents of Change’ AD Challengehttps://practicaldermatology.com/news/call-for-entries-sanofi-genzyme-and-regeneron-launches-2020-agents-of-change-ad-challenge/2460527/In recognition World Atopic Dermatitis (AD) Day, Sanofi Genzyme and Regeneron are launching the 2020 ‘Agents of Change’ AD Challenge, a
- Leadership Changes Take Place at SkinCeuticalshttps://practicaldermatology.com/news/leadership-changes-at-skinceuticals/2461069/Stephanie Kramer is now SkinCeutical’s Global General Manager, and Amy Sloan is the Head of SkinCeuticals U.S, the company reports Sloan brings 15 years of global and U.S. beauty industry experience - 10 of those years with SkinCeuticals - to the role of Head o
- Sinclair Pharma Announces Leadership Changeshttps://practicaldermatology.com/news/sinclair-pharma-announces-leadership-changes/2457491/Sinclair Pharma Limited reported that effective at the end of the year, Doug Abel has resigned his position as Head of North America and President of Silhouette Lift, Inc., to lead a new aesthetic venture and has licensed the US sales and marketing rights to the Refine Support System from Sinclai
- Valeant Pharmaceuticals Comments On Management Changehttps://practicaldermatology.com/news/valeant-pharmaceuticals-comments-on-management-change/2458668/Valeant Pharmaceuticals International, Inc. today issued the following comments in response to inquiries from investors regarding Deb Jorn's departure from Valeant.